Increased Akt-mTOR Signaling in Lung Epithelium Is Associated with Respiratory Distress Syndrome in Mice

ABSTRACT Pregnancy in women with diabetes is associated with a higher risk of perinatal complications. In particular, infants of diabetic mothers frequently suffer from respiratory distress syndrome (RDS), which is a leading cause of death in preterm infants and is considered to be primarily due to hyperinsulinemia in infants in response to maternal hyperglycemia. To elucidate the mechanism of how insulin signaling induces RDS, bronchoalveolar epithelium-specific Akt1 transgenic (TG) mice were generated. Akt1 overexpression in fetal lung epithelium resulted in RDS in preterm infants born by Caesarean section at embryonic day 18.5 (E18.5). The expression levels of hypoxia-inducible factor 2α (HIF-2α) and its target vascular endothelial growth factor (VEGF) were downregulated in the lung of Akt1 TG mice. Inhibition of the Akt-mammalian target of rapamycin (mTOR) signaling axis by rapamycin restored the expression of VEGF and improved the lung pathology of Akt1 TG pups. Rapamycin also attenuated the RDS phenotype in wild-type mice delivered preterm at E17.5. In cultured lung epithelial cells, insulin reduced VEGF expression and transcriptional activity of HIF-2 on VEGF promoter in an mTOR-dependent manner. Thus, aberrant activation of the Akt-mTOR pathway in lung epithelium plays a causal role in the pathogenesis of infant RDS, presumably through downregulation of HIF-2-dependent VEGF expression in the lung.

[1]  Q. Xue,et al.  Rapamycin Inhibition of the Akt/mTOR Pathway Blocks Select Stages of VEGF-A164–Driven Angiogenesis, in Part by Blocking S6Kinase , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Raphael Kopan,et al.  rtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouse. , 2009, Developmental biology.

[3]  S. Levkoff,et al.  Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[4]  E. Morrisey,et al.  A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration , 2008, Nature Genetics.

[5]  A. R. Thitoff,et al.  Conditional deletion of Pten causes bronchiolar hyperplasia. , 2008, American journal of respiratory cell and molecular biology.

[6]  T. Mak,et al.  Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. , 2007, The Journal of clinical investigation.

[7]  J. Neilson,et al.  Calcineurin/Nfat signaling is required for perinatal lung maturation and function. , 2006, The Journal of clinical investigation.

[8]  C. Kahn,et al.  Critical nodes in signalling pathways: insights into insulin action , 2006, Nature Reviews Molecular Cell Biology.

[9]  I. Shiojima,et al.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. , 2005, The Journal of clinical investigation.

[10]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[11]  E. Hannan,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[12]  Tine D Clausen,et al.  Poor pregnancy outcome in women with type 2 diabetes. , 2005, Diabetes care.

[13]  H. Beck-Nielsen,et al.  Outcomes in Type 1 Diabetic Pregnancies: A nationwide, population-based study , 2004 .

[14]  W. Aird,et al.  Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  W. Manning,et al.  Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice , 2003, Circulation.

[16]  J. Whitsett,et al.  Hydrophobic surfactant proteins in lung function and disease. , 2002, The New England journal of medicine.

[17]  M. Birnbaum,et al.  Regulation of Angiogenesis by Glycogen Synthase Kinase-3β* , 2002, The Journal of Biological Chemistry.

[18]  C. Kahn,et al.  Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status* , 2002, The Journal of Biological Chemistry.

[19]  Christine C. Hudson,et al.  Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin , 2002, Molecular and Cellular Biology.

[20]  Susan E. Wert,et al.  Early restriction of peripheral and proximal cell lineages during formation of the lung , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Till Acker,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[22]  D. Feig,et al.  Type 2 diabetes in pregnancy: a growing concern , 2002, The Lancet.

[23]  M. Rämet,et al.  Surfactant in respiratory distress syndrome and lung injury. , 2001, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[24]  J. Tichelaar,et al.  Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.

[25]  David Warburton,et al.  The molecular basis of lung morphogenesis , 2000, Mechanisms of Development.

[26]  C. Hsieh,et al.  Generation of a Dominant-negative Mutant of Endothelial PAS Domain Protein 1 by Deletion of a Potent C-terminal Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[27]  T. Mäkelä,et al.  Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development , 1999, Mechanisms of Development.

[28]  N. Shaw,et al.  Neonatal respiratory distress syndrome. , 1994, Archives of disease in childhood. Fetal and neonatal edition.

[29]  S. Guttentag,et al.  Delayed hydrophobic surfactant protein (SP-B, SP-C) expression in fetuses of streptozotocin-treated rats. , 1992, American journal of respiratory cell and molecular biology.

[30]  J. M. Snyder,et al.  Insulin regulation of messenger ribonucleic acid for the surfactant-associated proteins in human fetal lung in vitro. , 1992, Endocrinology.

[31]  S. Guttentag,et al.  Surfactant protein A expression is delayed in fetuses of streptozotocin-treated rats. , 1992, The American journal of physiology.

[32]  R. Schreiner,et al.  Infants of diabetic mothers. , 1978, The Journal of the Indiana State Medical Association.

[33]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.

[34]  J. Stockman.  Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes , 2007 .

[35]  K. Stenmark,et al.  Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. , 2005, Annual review of physiology.

[36]  P. Carmeliet,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.